415 related articles for article (PubMed ID: 11014213)
21. Regulation of estrogen receptor concentration and activity by an erbB/HER ligand in breast carcinoma cell lines.
Saceda M; Grunt TW; Colomer R; Lippman ME; Lupu R; Martin MB
Endocrinology; 1996 Oct; 137(10):4322-30. PubMed ID: 8828492
[TBL] [Abstract][Full Text] [Related]
22. Estrogenic actions of RU486 in hormone-responsive MCF-7 human breast cancer cells.
Jeng MH; Langan-Fahey SM; Jordan VC
Endocrinology; 1993 Jun; 132(6):2622-30. PubMed ID: 8504763
[TBL] [Abstract][Full Text] [Related]
23. Oxytocin modulates estrogen receptor alpha expression and function in MCF7 human breast cancer cells.
Cassoni P; Catalano MG; Sapino A; Marrocco T; Fazzari A; Bussolati G; Fortunati N
Int J Oncol; 2002 Aug; 21(2):375-8. PubMed ID: 12118334
[TBL] [Abstract][Full Text] [Related]
24. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
[TBL] [Abstract][Full Text] [Related]
25. Ginsenoside-Rb1 from Panax ginseng C.A. Meyer activates estrogen receptor-alpha and -beta, independent of ligand binding.
Cho J; Park W; Lee S; Ahn W; Lee Y
J Clin Endocrinol Metab; 2004 Jul; 89(7):3510-5. PubMed ID: 15240639
[TBL] [Abstract][Full Text] [Related]
26. Regulation of estrogen receptor-alpha gene expression by 1, 25-dihydroxyvitamin D in MCF-7 cells.
Stoica A; Saceda M; Fakhro A; Solomon HB; Fenster BD; Martin MB
J Cell Biochem; 1999 Dec; 75(4):640-51. PubMed ID: 10572247
[TBL] [Abstract][Full Text] [Related]
27. Unliganded and liganded estrogen receptors protect against cancer invasion via different mechanisms.
Platet N; Cunat S; Chalbos D; Rochefort H; Garcia M
Mol Endocrinol; 2000 Jul; 14(7):999-1009. PubMed ID: 10894150
[TBL] [Abstract][Full Text] [Related]
28. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
Herman ME; Katzenellenbogen BS
Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416
[TBL] [Abstract][Full Text] [Related]
29. Regulation of pS2 gene expression by affinity labeling and reversibly binding estrogens and antiestrogens: comparison of effects on the native gene and on pS2-chloramphenicol acetyltransferase fusion genes transfected into MCF-7 human breast cancer cells.
Weaver CA; Springer PA; Katzenellenbogen BS
Mol Endocrinol; 1988 Oct; 2(10):936-45. PubMed ID: 2460749
[TBL] [Abstract][Full Text] [Related]
30. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation.
Duan R; Porter W; Safe S
Endocrinology; 1998 Apr; 139(4):1981-90. PubMed ID: 9528985
[TBL] [Abstract][Full Text] [Related]
31. The role of transforming growth factor-beta in the regulation of estrogen receptor expression in the MCF-7 breast cancer cell line.
Stoica A; Saceda M; Fakhro A; Solomon HB; Fenster BD; Martin MB
Endocrinology; 1997 Apr; 138(4):1498-505. PubMed ID: 9075708
[TBL] [Abstract][Full Text] [Related]
32. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.
Oesterreich S; Zhang P; Guler RL; Sun X; Curran EM; Welshons WV; Osborne CK; Lee AV
Cancer Res; 2001 Aug; 61(15):5771-7. PubMed ID: 11479214
[TBL] [Abstract][Full Text] [Related]
33. Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions.
Murphy CS; Pink JJ; Jordan VC
Cancer Res; 1990 Nov; 50(22):7285-92. PubMed ID: 2224859
[TBL] [Abstract][Full Text] [Related]
34. Identification of a novel transferable cis element in the promoter of an estrogen-responsive gene that modulates sensitivity to hormone and antihormone.
Montano MM; Kraus WL; Katzenellenbogen BS
Mol Endocrinol; 1997 Mar; 11(3):330-41. PubMed ID: 9058379
[TBL] [Abstract][Full Text] [Related]
35. Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors.
Lu D; Kiriyama Y; Lee KY; Giguère V
Cancer Res; 2001 Sep; 61(18):6755-61. PubMed ID: 11559547
[TBL] [Abstract][Full Text] [Related]
36. An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription.
Bollig A; Miksicek RJ
Mol Endocrinol; 2000 May; 14(5):634-49. PubMed ID: 10809228
[TBL] [Abstract][Full Text] [Related]
37. Studies on the development of resistance to the pure antiestrogen Faslodex in three human breast cancer cell lines.
Sommer A; Hoffmann J; Lichtner RB; Schneider MR; Parczyk K
J Steroid Biochem Mol Biol; 2003 May; 85(1):33-47. PubMed ID: 12798355
[TBL] [Abstract][Full Text] [Related]
38. Regulation of estrogen receptor-alpha gene expression by epidermal growth factor.
Stoica A; Saceda M; Doraiswamy VL; Coleman C; Martin MB
J Endocrinol; 2000 May; 165(2):371-8. PubMed ID: 10810301
[TBL] [Abstract][Full Text] [Related]
39. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
40. Fos and Jun inhibit estrogen-induced transcription of the human progesterone receptor gene through an activator protein-1 site.
Petz LN; Ziegler YS; Schultz JR; Nardulli AM
Mol Endocrinol; 2004 Mar; 18(3):521-32. PubMed ID: 14684847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
